News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Phase 3 Clinical Trial Approval for YS Biopharma's PIKA Rabies Vaccine Granted by Philippines FDA
Friday, June 02, 2023YS Biopharma Co Ltd NASDAQ YS has announced that its PIKA Rabies Vaccine has received Phase clinical trial approval from the Food and Drug Administration of the Philippines The vaccine is being developed by YS Biopharma a global biopharmaceutical co...
Impact Therapeutics and Eikon Therapeutics Collaborate Globally to Develop and Commercialize PARP1 Selective Inhibitors
Friday, June 02, 2023IMPACT Therapeutics and Eikon Therapeutics have recently announced a global license and collaboration agreement for the development of PARP selective inhibitors including IMP IMPACT Therapeutics is a biopharmaceutical company focused on discovering a...
Caris Life Sciences and ConcertAI Forge an Expanded Partnership to Develop a Pioneering Clinico-Genomic Research Platform Enabling Prospective Patient Matching
Friday, June 02, 2023Caris Life Sciences and ConcertAI have recently announced an expanded partnership in the field of translational sciences and clinical development solutions The companies aim to collaborate on the creation of a comprehensive database of molecular clin...
European Approval Granted to Novartis' Cosentyx® as the First and Only IL-17A Inhibitor for Hidradenitis Suppurativa
Friday, June 02, 2023Novartis has announced that the European Commission EC has approved Cosentyx secukinumab for the treatment of active moderate to severe hidradenitis suppurativa HS in adults who have not responded well to conventional systemic HS therapy This approva...
Olverembatinib by Ascentage Pharma Granted Second Breakthrough Therapy Designation in China for SDH-Deficient GIST Treatment
Wednesday, May 31, 2023Ascentage Pharma HK a global biopharmaceutical company focused on developing innovative therapies for cancer chronic hepatitis B CHB and agerelated diseases has recently announced that the Center for Drug Evaluation CDE of China National Medical Prod...
Yuhan Corporation and J INTS BIO Forge Licensing Agreement for Novel Drug Candidate Addressing HER2 in NSCLC
Wednesday, May 31, 2023Yuhan Corporation led by CEO WookJe Cho announced on May th that it has entered into an inlicense agreement with J INTS BIO headed by CEO Anna Jo The agreement involves the acquisition of a Tyrosine Kinase Inhibitor TKI known as JINA which specifical...
FDA Approves Epcoritamab, Developed by AbbVie, as the First Bispecific Antibody for the Treatment of Adults with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R)
Tuesday, May 30, 2023AbbVie a pharmaceutical company made an announcement on May regarding the approval of epcoritamab by the US Food and Drug Administration FDA Epcoritamab is a bispecific antibody that has been approved as the first and only treatment option for adul...
FDA Grants Priority Review to Bristol Myers Squibb's Application for Repotrectinib in Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
Tuesday, May 30, 2023Bristol Myers Squibb NYSE BMY has announced that the US Food and Drug Administration FDA has accepted the New Drug Application NDA for repotrectinib a nextgeneration tyrosine kinase inhibitor TKI for the treatment of patients with ROSpositive locally...
Kane Biotech Announces FDA 510(k) Clearance for its coactiv+™ Antimicrobial Wound Gel
Friday, May 26, 2023Kane Biotech Inc TSXVKNE OTCQBKNBIF the Company or Kane Biotech announces that on May it received k clearance of its coactiv Antimicrobial Wound Gel from the US Food and Drug Administration FDA for the management of ulcers including diabetic foot a...
Takeda and HUTCHMED Announce New Drug Application (NDA) - Fruquintinib - for Treatment of Experiencing Metastatic Colorectal Cancer Has Been Accepted for Priority Review
Friday, May 26, 2023OSAKA Japan CAMBRIDGE Mass HONG KONG SHANGHAI FLORHAM PARK NJ BUSINESS WIRE Takeda TSENYSETAK HUTCHMED China Limited NasdaqAIMHCM HKEX HUTCHMED today announced that the FDA Food and Drug Administration has granted permission to conduct a prior...
